Sedative and cardiorespiratory effects of acepromazine or atropine given before dexmedetomidine in dogs

Nenhuma Miniatura disponível

Data

2008-06-28

Autores

Alvaides, R. K. [UNESP]
Teixeira Neto, Francisco José [UNESP]
Aguiar, Antonio José de Araújo [UNESP]
Campagnol, D. [UNESP]
Steagall, P. V. M. [UNESP]

Título da Revista

ISSN da Revista

Título de Volume

Editor

British Veterinary Assoc

Resumo

To test the hypothesis that acepromazine could potentiate the sedative actions and attenuate the pressor response induced by dexmedetomidine, the effects of acepromazine or atropine were compared in six healthy adult dogs treated with this alpha(2)-agonist. In a randomised block design, the dogs received intravenous doses of either physiological saline, 0.05 mg/kg acepromazine or 0.04 mg/kg atropine, 15 minutes before an intravenous dose of 5 mu g/kg dexmedetomidine. The dogs' heart rate was reduced by 50 to 63 per cent from baseline and their mean arterial blood pressure was increased transiently from baseline for 20 minutes after the dexmedetomidine. Atropine prevented the alpha(2)-agonist-induced bradycardia and increased the severity and duration of the hypertension, but acepromazine did not substantially modify the cardiovascular effects of the a2-agonist, except for a slight reduction in the magnitude and duration of its pressor effects. The dexmedetomidine induced moderate to intense sedation in all the treatments, but the dogs' sedation scores did not differ among treatments. The combination of acepromazine with dexmedetomidine had no obvious advantages in comparison with dexmedetomidine alone, but the administration of atropine before dexmedetomidine is contraindicated because of a severe hypertensive response.

Descrição

Palavras-chave

Como citar

Veterinary Record. London: British Veterinary Assoc, v. 162, n. 26, p. 852-856, 2008.